Hence, further studies may allow us to shed further light in the design of other species with enhanced activities aimed to develop new, specific, yet safer antineoplastic agents, related to the breast cancer estrogen receptors (ERα and GPER). The gene discussed is ESR1; the disease is breast carcinoma.